401 related articles for article (PubMed ID: 18176567)
1. Transcription factor EBF restricts alternative lineage options and promotes B cell fate commitment independently of Pax5.
Pongubala JM; Northrup DL; Lancki DW; Medina KL; Treiber T; Bertolino E; Thomas M; Grosschedl R; Allman D; Singh H
Nat Immunol; 2008 Feb; 9(2):203-15. PubMed ID: 18176567
[TBL] [Abstract][Full Text] [Related]
2. Assembling a gene regulatory network for specification of the B cell fate.
Medina KL; Pongubala JM; Reddy KL; Lancki DW; Dekoter R; Kieslinger M; Grosschedl R; Singh H
Dev Cell; 2004 Oct; 7(4):607-17. PubMed ID: 15469848
[TBL] [Abstract][Full Text] [Related]
3. Antagonistic effect of CCAAT enhancer-binding protein-alpha and Pax5 in myeloid or lymphoid lineage choice in common lymphoid progenitors.
Hsu CL; King-Fleischman AG; Lai AY; Matsumoto Y; Weissman IL; Kondo M
Proc Natl Acad Sci U S A; 2006 Jan; 103(3):672-7. PubMed ID: 16407117
[TBL] [Abstract][Full Text] [Related]
4. E2A Antagonizes PU.1 Activity through Inhibition of DNA Binding.
Rogers JH; Owens KS; Kurkewich J; Klopfenstein N; Iyer SR; Simon MC; Dahl R
Biomed Res Int; 2016; 2016():3983686. PubMed ID: 26942192
[TBL] [Abstract][Full Text] [Related]
5. Reduced EBF expression underlies loss of B-cell potential of hematopoietic progenitors with age.
Lescale C; Dias S; Maës J; Cumano A; Szabo P; Charron D; Weksler ME; Dosquet C; Vieira P; Goodhardt M
Aging Cell; 2010 Jun; 9(3):410-9. PubMed ID: 20331442
[TBL] [Abstract][Full Text] [Related]
6. Immunologic regulation of bone development.
Horowitz MC; Lorenzo JA
Adv Exp Med Biol; 2007; 602():47-56. PubMed ID: 17966387
[TBL] [Abstract][Full Text] [Related]
7. Knockdown of Pu.1 by small interfering RNA in CD34+ embryoid body cells derived from mouse ES cells turns cell fate determination to pro-B cells.
Zou GM; Chen JJ; Yoder MC; Wu W; Rowley JD
Proc Natl Acad Sci U S A; 2005 Sep; 102(37):13236-41. PubMed ID: 16141339
[TBL] [Abstract][Full Text] [Related]
8. Myeloid lineage switch of Pax5 mutant but not wild-type B cell progenitors by C/EBPalpha and GATA factors.
Heavey B; Charalambous C; Cobaleda C; Busslinger M
EMBO J; 2003 Aug; 22(15):3887-97. PubMed ID: 12881423
[TBL] [Abstract][Full Text] [Related]
9. Enforced expression of EBF in hematopoietic stem cells restricts lymphopoiesis to the B cell lineage.
Zhang Z; Cotta CV; Stephan RP; deGuzman CG; Klug CA
EMBO J; 2003 Sep; 22(18):4759-69. PubMed ID: 12970188
[TBL] [Abstract][Full Text] [Related]
10. In utero exposure to alcohol alters cell fate decisions by hematopoietic progenitors in the bone marrow of offspring mice during neonatal development.
Wang H; Zhou H; Moscatello KM; Dixon C; Brunson LE; Chervenak R; Chervenak DC; Zhao X; Wolcott RM
Cell Immunol; 2006 Jan; 239(1):75-85. PubMed ID: 16797505
[TBL] [Abstract][Full Text] [Related]
11. Pax5 determines B- versus T-cell fate and does not block early myeloid-lineage development.
Cotta CV; Zhang Z; Kim HG; Klug CA
Blood; 2003 Jun; 101(11):4342-6. PubMed ID: 12560221
[TBL] [Abstract][Full Text] [Related]
12. The mechanism of repression of the myeloid-specific c-fms gene by Pax5 during B lineage restriction.
Tagoh H; Ingram R; Wilson N; Salvagiotto G; Warren AJ; Clarke D; Busslinger M; Bonifer C
EMBO J; 2006 Mar; 25(5):1070-80. PubMed ID: 16482219
[TBL] [Abstract][Full Text] [Related]
13. Poised lineage specification in multipotential hematopoietic stem and progenitor cells by the polycomb protein Bmi1.
Oguro H; Yuan J; Ichikawa H; Ikawa T; Yamazaki S; Kawamoto H; Nakauchi H; Iwama A
Cell Stem Cell; 2010 Mar; 6(3):279-86. PubMed ID: 20207230
[TBL] [Abstract][Full Text] [Related]
14. Early B cell factor: Regulator of B lineage specification and commitment.
Lukin K; Fields S; Hartley J; Hagman J
Semin Immunol; 2008 Aug; 20(4):221-7. PubMed ID: 18722139
[TBL] [Abstract][Full Text] [Related]
15. Oscillation between B-lymphoid and myeloid lineages in Myc-induced hematopoietic tumors following spontaneous silencing/reactivation of the EBF/Pax5 pathway.
Yu D; Allman D; Goldschmidt MH; Atchison ML; Monroe JG; Thomas-Tikhonenko A
Blood; 2003 Mar; 101(5):1950-5. PubMed ID: 12406913
[TBL] [Abstract][Full Text] [Related]
16. Long-term in vivo reconstitution of T-cell development by Pax5-deficient B-cell progenitors.
Rolink AG; Nutt SL; Melchers F; Busslinger M
Nature; 1999 Oct; 401(6753):603-6. PubMed ID: 10524629
[TBL] [Abstract][Full Text] [Related]
17. Commitment to the B-lymphoid lineage depends on the transcription factor Pax5.
Nutt SL; Heavey B; Rolink AG; Busslinger M
Nature; 1999 Oct; 401(6753):556-62. PubMed ID: 10524622
[TBL] [Abstract][Full Text] [Related]
18. Corecruitment of the Grg4 repressor by PU.1 is critical for Pax5-mediated repression of B-cell-specific genes.
Linderson Y; Eberhard D; Malin S; Johansson A; Busslinger M; Pettersson S
EMBO Rep; 2004 Mar; 5(3):291-6. PubMed ID: 14993928
[TBL] [Abstract][Full Text] [Related]
19. Restricted STAT5 activation dictates appropriate thymic B versus T cell lineage commitment.
Goetz CA; Harmon IR; O'Neil JJ; Burchill MA; Johanns TM; Farrar MA
J Immunol; 2005 Jun; 174(12):7753-63. PubMed ID: 15944278
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-7 is necessary to maintain the B cell potential in common lymphoid progenitors.
Dias S; Silva H; Cumano A; Vieira P
J Exp Med; 2005 Mar; 201(6):971-9. PubMed ID: 15767371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
